METFinancial Services · Insurance - LifeThe 18 Wall Street analysts covering MetLife, Inc. hold a median 12-month price target of $110 — +7.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 56 of 100 as at 3 Nov 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores MetLife, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (92): The shares have been drifting up relative to others.
Accruals (23): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on MET, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +7.0% from it.
Of the 20 most recent actions, 10 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 21 Oct 2026 | TD Cowen | Maintains | Buy | $110 → $114 |
| 15 Oct 2026 | JP Morgan | Maintains | Overweight | $108 → $110 |
| 12 Oct 2026 | Wells Fargo | Maintains | Overweight | $109 → $110 |
| 12 Oct 2026 | Wells Fargo | Maintains | Overweight | — |
| 7 Oct 2026 | Barclays | Maintains | Overweight | $97 → $111 |
| 7 Oct 2026 | Barclays | Maintains | Overweight | — |
| 7 Oct 2026 | Mizuho | Maintains | Outperform | — |
| 7 Oct 2026 | Mizuho | Maintains | Outperform | $112 → $109 |
| 6 Oct 2026 | UBS | Maintains | Buy | — |
| 6 Oct 2026 | UBS | Maintains | Buy | $105 → $110 |
| 5 Oct 2026 | TD Cowen | Maintains | Buy | — |
| 5 Oct 2026 | TD Cowen | Maintains | Buy | $105 → $110 |
| 22 Sept 2026 | Piper Sandler | Upgrade | Overweight | — |
| 22 Sept 2026 | Piper Sandler | Upgrade | Overweight | $99 → $110 |
| 24 Aug 2026 | Morgan Stanley | Maintains | Overweight | $103 → $111 |
| 24 Aug 2026 | Morgan Stanley | Maintains | Overweight | — |
| 19 Aug 2026 | Wells Fargo | Maintains | Overweight | — |
| 19 Aug 2026 | Wells Fargo | Maintains | Overweight | $101 → $109 |
| 11 Aug 2026 | JP Morgan | Maintains | Overweight | — |
| 11 Aug 2026 | JP Morgan | Maintains | Overweight | $106 → $108 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
MET appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, MetLife, Inc. returned +32.1% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 38% of US stocks
Cheaper than 72% of US stocks
Cheaper than 37% of US stocks
Cheaper than 24% of US stocks
Higher than 54% of US stocks
Higher than 38% of US stocks
Higher than 56% of US stocks
Higher than 58% of US stocks
Higher than 70% of US stocks
Higher than 46% of US stocks
Higher than 82% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
MetLife, Inc. has a market value of $64.1B and an enterprise value of $87.7B.
Revenue in the twelve months to 30 June 2026: $77.7B. The latest quarter grew 10.5% year on year.
Net income over the same four quarters: $3.7B, a 4.7% net margin.
Diluted earnings per share, trailing twelve months: $5.23.
Free cash flow in the twelve months to 30 June 2026: $15.6B.
MetLife, Inc. spent $3.4B on share buybacks and $1.7B on dividends in the twelve months to 30 June 2026.
Trailing P/E: 19.3×; forward P/E: 9.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.35%, paying out 44% of earnings.
MetLife, Inc. employs 46,000 people — $1.7M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own MetLife, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
MetLife announced that CFO John McCallion provided a third-quarter 2026 financial update video.
Why it matters — MET watchers may consult the video for the company's financial update from its CFO.
MetLife reported third-quarter 2026 net income of $2.4 billion, or $3.67 per share, up 187%. Adjusted earnings rose 12% to $1.8 billion, with the company citing higher variable investment income, broad-based volume growth and favorable underwriting.
Why it matters — The results provide MET watchers with an update on quarterly earnings growth and the factors MetLife said contributed to it.
The article says investors spent much of 2026 favoring large technology companies while insurers received less attention. Its headline suggests rate hikes may be approaching and frames four insurance stocks in light of historical performance.
Why it matters — The item places insurers in a discussion of possible rate hikes and shifting investor attention, providing context for readers following MetLife.
A Zacks report frames MetLife, Allstate, AFLAC and Prudential as insurers to watch for a potential third-quarter 2026 earnings beat. It notes that Marsh, Aon and The Hartford have already reported solid year-over-year growth, providing an early industry read.
Why it matters — MetLife watchers may compare its upcoming results with peers as third-quarter earnings reports emerge.
The article says MetLife’s Q3 earnings may benefit from strong segment growth and higher premiums, while weaker investment income and Asia results could limit gains.
Why it matters — MET watchers may weigh the potential contributions from segment growth and premiums against weakness in investment income and Asia results.
The 18 Wall Street analysts covering MetLife, Inc. have a median 12-month price target of $110, with estimates ranging from $84 to $119. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 18 analysts covering MetLife, Inc., 13 rate it a Buy, 4 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks MetLife, Inc. 56 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, MetLife, Inc. ranks 56 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (92 of 100).
No one can know that. What the data says: the median 12-month target from 18 analysts implies +7.0% from the last close, and Ticker Nerd's factor model ranks MetLife, Inc. 56 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering MetLife, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MET are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $84 to $119 over the next 12 months.
MetLife, Inc. returned +32.1% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
MetLife, Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers.
The most recent item we track (Business Wire, 4 Nov 2026): "MetLife CFO John McCallion Provides Third Quarter 2026 Financial Update Video". MetLife announced that CFO John McCallion provided a third-quarter 2026 financial update video.
MetLife, Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers. Its business spans group life, dental, disability, vision, accident and health coverage, along with retirement and income solutions such as pension risk transfer and structured settlements. MetLife also offers individual protection and savings products in international markets and serves corporate clients through a broad employee benefits platform. The company operates across major regions including the United States, Asia, Latin America, and Europe, the Middle East, and Africa, supported by diversified distribution channels that include employers, brokers, agents, and bancassurance partners. Through its insurance and investment businesses, MetLife plays a central role in helping households, employers, and institutions manage risk, protect assets, and fund long-term financial needs.
CEO Mr. Michel Abbas Khalaf · 46,000 employees · United States · https://www.metlife.com
